TPB15 is an orally effective Hedgehog (Hh) signaling inhibitor with potent antitumor activity and low toxicity; it significantly induces cell cycle arrest and apoptosis in MDA-MB-468 cells, blocks Smoothened (Smo) translocation to cilia, reduces Smo protein and mRNA expression, and inhibits the expression of the downstream effector glioma-associated oncogene 1 (Gli1).